ProCE Banner Activity

CAR T-Cell Therapy in Multiple Myeloma: Understanding and Communicating Current Evidence

Slideset

Download this slideset from expert advanced practice providers with the latest evidence for CAR T-cell therapy in multiple myeloma.

Released: January 08, 2025

Expiration: January 07, 2026

Share

Faculty

Beth Faiman

Beth Faiman, PhD, MSN, APN-BC, AOCN, BMTCN, FAAN, FAPO

Cleveland Clinic Taussig Cancer Institute
Department of Hematology and Medical Oncology
Member, Population and Cancer Prevention Program, Case Comprehensive Cancer Center
Cleveland, Ohio

Tiffany Richards

Tiffany Richards, PhD, ANP-BC, AOCNP

Nurse Practitioner
Department of Lymphoma/Myeloma
MD Anderson Cancer Center
Houston, Texas

 

Danielle Roberts

Danielle Roberts, PA-C

Associate Chief of Education for APPs
Director, Hematology/Oncology APP Fellowship
Winship Cancer Institute at Emory University
Atlanta, Georgia

Provided by

Provided by Partners for Advancing Clinical Education (PACE) in partnership with Practicing Clinicians Exchange, LLC and Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from Janssen Biotech, Inc. administered by Janssen Scientific Affairs, LLC and Legend Biotech USA, Inc.

Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC

Legend Biotech USA Inc.

Partners

Clinical Care Options, LLC

ProCE Banner

Practicing Clinicians Exchange

ProCE Banner